An intensive therapy for children with neuromotor disorders developed by Virginia Tech researchers shows promise for kids ...
As the world recognizes Rare Disease Day on Feb. 28, Rockville-based biotechnology company, REGENXBIO is working to change ...
The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...
Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback